Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia

Preclinical and clinical studies have suggested that fibroblast growth factor (FGF) system contributed to the onset and development of schizophrenia (SCZ). However, there was no strong clinical evidence to link an individual FGF with SCZ. In this study, we aim to measure blood FGF9 levels in the pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Ling, Yu, Yun, Hu, Yang, Wu, Huan-Tong, Li, Xue-Song, Chen, Guang-Yang, Cheng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082542/
https://www.ncbi.nlm.nih.gov/pubmed/35546939
http://dx.doi.org/10.3389/fpsyt.2022.788677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082542/
https://www.ncbi.nlm.nih.gov/pubmed/35546939
http://dx.doi.org/10.3389/fpsyt.2022.788677

Ejemplares similares